Merit Medical SystemsMMSI
MMSI
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
12,410% more call options, than puts
Call options by funds: $89.1M | Put options by funds: $712K
257% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 23
17% more funds holding
Funds holding: 319 [Q2] → 372 (+53) [Q3]
12% more repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 114
10% more capital invested
Capital invested by funds: $5.34B [Q2] → $5.88B (+$538M) [Q3]
4.35% less ownership
Funds ownership: 106.89% [Q2] → 102.54% (-4.35%) [Q3]
67% less funds holding in top 10
Funds holding in top 10: 3 [Q2] → 1 (-2) [Q3]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$109
6%
upside
Avg. target
$115
12%
upside
High target
$127
23%
upside
6 analyst ratings
6 positive
100%
0 neutral
0%
0 negative
0%
Needham Mike Matson 52% 1-year accuracy 64 / 122 met price target | 6%upside $109 | Buy Reiterated | 14 Jan 2025 |
Raymond James Jayson Bedford 63% 1-year accuracy 15 / 24 met price target | 7%upside $110 | Outperform Maintained | 31 Dec 2024 |
Barrington Research Michael Petusky 55% 1-year accuracy 38 / 69 met price target | 11%upside $114 | Outperform Maintained | 23 Dec 2024 |
Wells Fargo Larry Biegelsen 63% 1-year accuracy 29 / 46 met price target | 17%upside $120 | Overweight Upgraded | 11 Dec 2024 |
Canaccord Genuity Jon Young 67% 1-year accuracy 4 / 6 met price target | 23%upside $127 | Buy Maintained | 9 Dec 2024 |
Financial journalist opinion
Based on 10 articles about MMSI published over the past 30 days
Positive
Zacks Investment Research
3 hours ago
3 Reasons Why Growth Investors Shouldn't Overlook Merit Medical (MMSI)
Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.
Neutral
Zacks Investment Research
3 days ago
BDX or MMSI: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
Positive
Zacks Investment Research
3 days ago
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Positive
Zacks Investment Research
5 days ago
Merit Medical Stock Gains Following Solid Preliminary Q4 Revenues
MMSI's revenue growth in the fourth quarter is likely to have been boosted by continued robust adoption of its products.
Neutral
GlobeNewsWire
6 days ago
Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025
* Constant currency revenue is a non-GAAP financial measure. A reconciliation of this financial measure to its most directly comparable GAAP financial measure is included under the heading “Non-GAAP Financial Measure” below.
Positive
Zacks Investment Research
2 weeks ago
Is Merit Medical (MMSI) a Solid Growth Stock? 3 Reasons to Think "Yes"
Merit Medical (MMSI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Positive
Zacks Investment Research
2 weeks ago
Here's Why You Should Add MMSI Stock to Your Portfolio Now
Merit Medical's strong product portfolio raises optimism about the stock.
Positive
Zacks Investment Research
2 weeks ago
BDX vs. MMSI: Which Stock Is the Better Value Option?
Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?
Positive
Zacks Investment Research
2 weeks ago
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Positive
Zacks Investment Research
4 weeks ago
Merit Medical Stock Rises Following FDA Nod for WRAPSODY Device
MMSI announces FDA approval for the WRAPSODY Cell-Impermeable Endoprosthesis.
Charts implemented using Lightweight Charts™